Literature DB >> 27873631

Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece.

Helena C Maltezou1, Flora Kontopidou2, Xanthi Dedoukou2, Panagiotis Katerelos2, Georgios-Michael Gourgoulis2, Paraskeui Tsonou2, Antonis Maragos2, Panagiotis Gargalianos2, Achilleas Gikas2, Charalambos Gogos2, Ioannis Koumis2, Moyssis Lelekis2, Efstratios Maltezos2, Georgia Margariti2, Pavlos Nikolaidis2, Angelos Pefanis2, George Petrikkos2, George Syrogiannopoulos2, Athanassios Tsakris2, Alkiviadis Vatopoulos2, George Saroglou2, Jenny Kremastinou2, George L Daikos2.   

Abstract

The prevalence of carbapenem-resistant pathogens (CRPs) has increased worldwide. Given the importance of CRPs for public health and the high rates of carbapenem resistance observed in Greece, the Hellenic Center for Disease Control and Prevention (HCDCP) under the auspices of the Ministry of Health has undertaken initiatives to develop an Action Plan (i) to estimate the burden of CRP infections in acute-care hospitals in Greece and (ii) to implement infection control measures to limit the intrahospital transmission of these organisms. Starting in November 2010, specific infections caused by CRPs were reported to the HCDCP weekly. Results showed that CRP infections constitute a significant public health problem in acute-care hospitals in this country, with a mean incidence of 0.48 per 1000 patient-days and a crude 28-day mortality rate of 34.4%. The second phase of the Action Plan consists of systemic evaluation for adherence to an infection control bundle including enhanced standard infection control practices, separation of carriers and infected patients from non-carriers, and strict implementation of contact precautions. Communication between hospitals and public health authorities has been established to facilitate rapid notification and feedback. Copyright Â
© 2013 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Action Plan; Carbapenem-resistant; Gram-negative; Hospital; Infection; Infection control; Nosocomial

Year:  2013        PMID: 27873631     DOI: 10.1016/j.jgar.2013.06.002

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  6 in total

1.  Ceftazidime-Avibactam To Treat Life-Threatening Infections by Carbapenem-Resistant Pathogens in Critically Ill Mechanically Ventilated Patients.

Authors:  Vasiliki Tsolaki; Konstantinos Mantzarlis; Athanasios Mpakalis; Ergina Malli; Fotios Tsimpoukas; Athanasia Tsirogianni; Constantinos Papagiannitsis; Paris Zygoulis; Maria-Eirini Papadonta; Efthimia Petinaki; Demosthenes Makris; Epaminondas Zakynthinos
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

2.  Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.

Authors:  Olga Tsiatsiou; Εlias Iosifidis; Aspasia Katragkou; Vasiliki Dimou; Kosmas Sarafidis; Theodoros Karampatakis; Charalampos Antachopoulos; Anagnostina Orfanou; Athanasios Tsakris; Vasiliki Drossou-Agakidou; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2014-07-02       Impact factor: 3.183

3.  Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting.

Authors:  Kalliopi Spyridopoulou; Mina Psichogiou; Vana Sypsa; Vivi Miriagou; Amalia Karapanou; Linos Hadjihannas; Leonidas Tzouvelekis; George L Daikos
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-06       Impact factor: 4.887

4.  Using Machine Learning Techniques to Aid Empirical Antibiotic Therapy Decisions in the Intensive Care Unit of a General Hospital in Greece.

Authors:  Georgios Feretzakis; Evangelos Loupelis; Aikaterini Sakagianni; Dimitris Kalles; Maria Martsoukou; Malvina Lada; Nikoletta Skarmoutsou; Constantinos Christopoulos; Konstantinos Valakis; Aikaterini Velentza; Stavroula Petropoulou; Sophia Michelidou; Konstantinos Alexiou
Journal:  Antibiotics (Basel)       Date:  2020-01-31

5.  Polymyxin Resistance in Clinical Isolates of K. pneumoniae in Brazil: Update on Molecular Mechanisms, Clonal Dissemination and Relationship With KPC-Producing Strains.

Authors:  Orlando C Conceição-Neto; Bianca Santos da Costa; Leilane da Silva Pontes; Melise Chaves Silveira; Lívia Helena Justo-da-Silva; Ivson Cassiano de Oliveira Santos; Camila Bastos Tavares Teixeira; Thamirys Rachel Tavares E Oliveira; Fernanda Stephens Hermes; Teca Calcagno Galvão; L Caetano M Antunes; Cláudio Marcos Rocha-de-Souza; Ana P D Carvalho-Assef
Journal:  Front Cell Infect Microbiol       Date:  2022-07-15       Impact factor: 6.073

6.  Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data.

Authors:  Amalia Papanikolopoulou; Helena C Maltezou; Athina Stoupis; Anastasia Pangalis; Christos Kouroumpetsis; Genovefa Chronopoulou; Yannis Kalofissoudis; Evangelos Kostares; Fotini Boufidou; Maria Karalexi; Vasiliki Koumaki; Nikos Pantazis; Athanasios Tsakris; Maria Kantzanou
Journal:  Antibiotics (Basel)       Date:  2022-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.